These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6196880)

  • 21. Neuraminidase-inhibition assay for the identification of influenza A virus neuraminidase subtype or neuraminidase antibody specificity.
    Pedersen JC
    Methods Mol Biol; 2008; 436():67-75. PubMed ID: 18370042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Virus infections of the central nervous system. Demonstration of viral antigens in paraffin-embedded autopsy material by the PAP technic (Sternberger)].
    Löhler J
    Acta Histochem Suppl; 1982; 25():107-11. PubMed ID: 6178128
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification of critical contact residues in the NC41 epitope of a subtype N9 influenza virus neuraminidase.
    Nuss JM; Whitaker PB; Air GM
    Proteins; 1993 Feb; 15(2):121-32. PubMed ID: 7680132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Strain differences in the neuraminidase specificity of subtype N 1].
    Zakstel'skaia LIa; Molibog EV; Khliustov SV; Isachenko VA
    Vopr Virusol; 1977; (6):279-82. PubMed ID: 74908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel means of identifying the neuraminidase type of currently circulating human A(H1) influenza viruses.
    Hurt AC; Barr IG; Komadina N; Hampson AW
    Virus Res; 2004 Jul; 103(1-2):79-83. PubMed ID: 15163493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defining the requirements for an antibody epitope on influenza virus neuraminidase: how tolerant are protein epitopes?
    Nuss JM; Air GM
    J Mol Biol; 1994 Jan; 235(2):747-59. PubMed ID: 7507170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
    Li S; Liu C; Klimov A; Subbarao K; Perdue ML; Mo D; Ji Y; Woods L; Hietala S; Bryant M
    J Infect Dis; 1999 May; 179(5):1132-8. PubMed ID: 10191214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Determination of the influenza A virus antigen in pharyngeal swabs using an enzyme immunoassay].
    Helbig JH; Muschner K; Füssel E; Witzleb W
    Z Gesamte Hyg; 1986 Oct; 32(10):615-7. PubMed ID: 3544534
    [No Abstract]   [Full Text] [Related]  

  • 29. Crystalline monoclonal fab fragment with specificity towards an influenza virus neuraminidase.
    Colman PM; Gough KH; Lilley GG; Blagrove RJ; Webster RG; Laver WG
    J Mol Biol; 1981 Nov; 152(3):609-14. PubMed ID: 7328664
    [No Abstract]   [Full Text] [Related]  

  • 30. Influenza A virus neuraminidase: regions of the protein potentially involved in virus-host interactions.
    Fanning TG; Reid AH; Taubenberger JK
    Virology; 2000 Oct; 276(2):417-23. PubMed ID: 11040132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can immunity induced by the human influenza virus N1 neuraminidase provide some protection from avian influenza H5N1 viruses?
    Gillim-Ross L; Subbarao K
    PLoS Med; 2007 Feb; 4(2):e91. PubMed ID: 17298170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimation of the neuraminidase content of influenza viruses and split-product vaccines by immunochromatography.
    Tanimoto T; Nakatsu R; Fuke I; Ishikawa T; Ishibashi M; Yamanishi K; Takahashi M; Tamura S
    Vaccine; 2005 Aug; 23(37):4598-609. PubMed ID: 15964668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in Canada.
    Abed Y; Hardy I; Li Y; Boivin G
    J Med Virol; 2002 Aug; 67(4):589-95. PubMed ID: 12116009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation of influenza viruses from rock partridges in Israel.
    Lipkind M; Shoham D; Shihmanter E
    Vet Rec; 1981 Dec; 109(24):540. PubMed ID: 7340094
    [No Abstract]   [Full Text] [Related]  

  • 35. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.
    Muhamed G; Greenbaum E; Zakay-Rones Z
    Isr Med Assoc J; 2006 Mar; 8(3):155-8. PubMed ID: 16599048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenic variation and the structure of influenza virus glycoproteins.
    Laver WG
    Microbiol Sci; 1984 May; 1(2):37-43. PubMed ID: 6444094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza virus A/swine-outbreaks in domestic pigs and antibody findings in human sera.
    Sinnecker H; Sinnecker R; Zilske E; Strey A; Leopoldt D
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):209-13. PubMed ID: 6316691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the binding of the Fab fragment of monoclonal antibody NC10 to influenza virus N9 neuraminidase from tern and whale using the BIAcore biosensor: effect of immobilization level and flow rate on kinetic analysis.
    Kortt AA; Nice E; Gruen LC
    Anal Biochem; 1999 Aug; 273(1):133-41. PubMed ID: 10452809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Looming flu pandemic has experts crying fowl.
    Clayton J
    Nat Med; 2003 Apr; 9(4):375. PubMed ID: 12669040
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.